Status:
UNKNOWN
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
Lead Sponsor:
British Columbia Cancer Agency
Conditions:
Neuroendocrine Tumors
Prostate Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Quantitative parameters obtained with dynamic whole body imaging using positron emission tomography (PET) can provide additional and complementary information to standard PET. Dynamic imaging allows f...
Detailed Description
This is a prospective single cohort study to evaluate the feasibility of dynamic whole body PET/CT in identifying and quantifying lesions where standard static PET has been negative or equivocal. 18F...
Eligibility Criteria
Inclusion
- All subjects:
- Meet the inclusion criteria for the appropriate main study (68Ga-DOTATOC PET/CT or 18F-DCFPyL PET/CT) or standard of care imaging.
- Able to not use the washroom for the duration of the dynamic imaging scanning.
- World health organization performance status 0-2
- Able to provide written informed consent/assent (or consent by guardian for subjects \<19 years)
- Patients must be able to tolerate the physical/logistical requirements of completing a PET scan including lying flat for up to 30 minutes and tolerating intravenous cannulation for injection.
Exclusion
- Pregnancy
- Unable to provide written consent
- Patients who are medically unstable ex: acute cardiac or respiratory distress, hypotensive
- Patients who exceed the safe weight limit of the PET/CT bed (204.5 kg) or who cannot fit through the PET/CT bore (diameter 70cm).
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04017104
Start Date
November 1 2019
End Date
August 1 2024
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BC Cancer
Vancouver, British Columbia, Canada, V5Z 4E6